A metabolite of the carcinogen 7,12-dimethylbenz[a]anthracene that reacts predominantly with adenine residues in DNA.
about
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityCarcinogenesis in mouse and human cells: parallels and paradoxes.Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates.Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis.Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis.The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skinCarcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.Chemopreventive potential of 3-[2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino]-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis.Carcinogen-induced animal models of head and neck squamous cell carcinoma.Evaluation of 3-(4'-(4″-fluorophenyl)-6'-phenylpyrimidin-2'-yl)-2-phenylthiazolidin-4-one for in vivo modulation of biomarkers of chemoprevention in the 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.In memoriam: Anthony Dipple.Imides modified benzopicenes: synthesis, solid structure and optoelectronic properties.Sunscreens protect from UV-promoted squamous cell carcinoma in mice chronically irradiated with doses of UV radiation insufficient to cause edema.Differential signaling pathway activation in 7,12-dimethylbenz[a] anthracene (DMBA)-treated mammary stem/progenitor cells from species with varying mammary cancer incidence
P2860
Q27021258-690E08A3-D9A6-4273-BA7B-7FFABC733353Q33846175-07D1560B-A1E8-47C9-8C24-41F9BA8D6187Q34467367-1B6CA3EE-3661-4A6A-B831-6F73D79FCF4CQ34963548-888C19EF-88DC-43DB-B29A-8619C9286E07Q35154879-B38D2F93-DFD4-44E4-BBB2-F284F081E68AQ36477850-3177A0B4-C280-42E8-A8DE-17B212D958EAQ37671272-230B2149-3DA4-4736-AC61-89162084C03FQ38445544-32EB9677-A959-4815-BB61-3ED198449EC4Q42726592-EBEF0784-60C7-40E0-A4DF-B39DA59C0F70Q46082883-E4BCDA76-C439-40D5-B6D6-32DF1E8BA5DCQ50247195-258A7B18-4307-4064-A265-2D9E9765219BQ50459290-974097C4-6E5A-4EFA-80C3-73DB766ACCE1Q53453053-F0DBC26F-F735-49DE-A02B-0437ED7440DFQ58697707-93A4671C-07E9-4F4B-B0B1-40BCB1D8CCE8
P2860
A metabolite of the carcinogen 7,12-dimethylbenz[a]anthracene that reacts predominantly with adenine residues in DNA.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
A metabolite of the carcinogen ...... with adenine residues in DNA.
@en
type
label
A metabolite of the carcinogen ...... with adenine residues in DNA.
@en
prefLabel
A metabolite of the carcinogen ...... with adenine residues in DNA.
@en
P2093
P356
P1433
P1476
A metabolite of the carcinogen ...... with adenine residues in DNA.
@en
P2093
Prakash AS
P304
P356
10.1093/CARCIN/9.9.1721
P407
P577
1988-09-01T00:00:00Z